Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma

Trial Overview

Am I Eligible?

Participating US Centers

City of Hope Comprehensive Cancer Center
Beckman Research Institute

This center is currently accepting patients.

Duarte, CA


Dana-Farber Cancer Institute

This center is currently accepting patients.

Boston, MA


Mayo Clinic

This center is currently accepting patients.

Jacksonville, FL


Winship Cancer Institute
Emory University

This center is currently accepting patients.

Atlanta, GA


Mount Sinai Hospital
Tisch Cancer Institute

This center is currently accepting patients.

New York, NY


Duke Cancer Center
Duke University Medical Center

This center is currently accepting patients.

Durham, NC


Stanford Cancer Institute

This center is currently accepting patients.

Stanford, CA


University of North Carolina
Lineberger Comprehensive Cancer Center

This center is currently accepting patients.

Chapel Hill, NC

ACCEPTING

This trial is currently open and accepting patients.



Additional Information
Trial Phase

Phase 1

Trial Enrollment

86 sparks required

Trial Sponsors
  • Hoffmann-La Roche
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;